High serum D-lactate in patients on continuous ambulatory peritoneal dialysis

Nephrol Dial Transplant. 1997 May;12(5):981-3. doi: 10.1093/ndt/12.5.981.

Abstract

Background: As abnormally high serum D-lactate levels may cause neurological impairment, we determined whether patients undergoing continuous ambulatory peritoneal dialysis (CAPD) with lactate-containing fluids have increased serum D-lactate concentrations.

Methods: D- and L-lactate concentrations were determined in peritoneal dialysis fluids and in serum from control subjects (n = 10), haemodialysis patients (n = 10), and CAPD patients (n = 30) before and after 1 h of dialysis.

Results: We found the median D-lactate concentration in Dianeal CAPD fluid to be 26 mM (range 19-27), whereas it was less than 0.5 mM in DPCA2 fluid. Control, haemodialysis, and CAPD (DPCA2) patient median serum D-lactate concentrations were below 0.07 mM. However, CAPD (Dianeal) patient serum D-lactate concentrations were 4-fold higher than controls (P < 0.0001), at 0.28 mM, an hour after instillation of D-lactate-containing fluid. Three patients, whose serum D-lactate averaged 0.59 mM, were found to have D-lactate concentrations at 0.22 mM after overnight cessation of dialysis.

Conclusion: We conclude that CAPD with D-lactate-containing fluids raises serum D-lactate to abnormal levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Dialysis Solutions / analysis
  • Female
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy
  • Lactic Acid / blood*
  • Lactic Acid / chemistry
  • Lactic Acid / metabolism
  • Male
  • Middle Aged
  • Nervous System Diseases / blood
  • Nervous System Diseases / etiology
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Renal Dialysis
  • Stereoisomerism

Substances

  • Dialysis Solutions
  • Lactic Acid